Alpha Cognition Inc (TSE:ACOG) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alpha Cognition Inc., a biopharmaceutical firm focusing on neurodegenerative diseases, has announced the resignation of CFO Don Kalkofen and the interim appointment of Jay Yoo, an experienced CPA and CFA. The company has recently achieved significant milestones, including the approval of their Alzheimer’s treatment ZUNVEYL, and is preparing for its early 2025 launch.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.